Welcome To AspenBio Pharma
AspenBio Pharma, Inc. is an emerging biotechnology company engaged in the discovery, development, manufacture, and licensing or marketing of products primarily for animal healthcare.
Founded in August 2000, and headquartered in Castle Rock, Colorado, we leverage our proprietary knowledge and technology towards the development of novel patented or patentable products we believe have substantial market potential.
We currently have a growing product pipeline including novel recombinant hormones and diagnostic tests in development. We also recently initiated our first Food and Drug Administration ("FDA") application with an Investigational New Animal Drug Application ("INADA") filing for one of our new recombinant hormones.
For a detailed company profile, please see About AspenBio Pharma.
Latest News
Click a Press Release headline below to view that item in a new window.
AspenBio Pharma Initiates Stock Buyback Plan »
April 25, 2008
AspenBio Pharma Advances AppyScore Towards Clinical Trials with Improved Specificity for Detecting Human Appendicitis »
April 23, 2008
AspenBio Pharma Enters Worldwide License Agreement for Bovine Reproduction Drugs »
April 7, 2008
AspenBio Pharma Appoints Dr. Mark Ratain to Board of Directors »
March 31, 2008
